Veraxa Biotech Holding AG (VRXAW) Current Leases (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Current Leases of $321669.5 for Q4 2025, up 80.17% year-over-year from $178537.4 in Q4 2024, and up 80.17% quarter-over-quarter from $178537.4 in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Current Leases (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Current Leases for 2 consecutive years, with $321669.5 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases rose 80.17% year-over-year to $321669.5; the TTM figure through Dec 2025 stood at $321669.5 (up 80.17% YoY), while the FY2025 annual figure was $321669.5, up 80.17% from the prior year.
- Current Leases improved to $321669.5 in Q4 2025 per VRXAW's latest filing, from $178537.4 in the prior quarter.
- Across five years, Current Leases topped out at $321669.5 in Q4 2025 and bottomed at $178537.4 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 321,669.50 |
| Dec 31, 2024 | 178,537.44 |